1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Metabolomics Biomarker Revenue
• 1.4 Market by Type
  • 1.4.1 Global Metabolomics Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Gas chromatography
  • 1.4.3 High-performance liquid chromatography
  • 1.4.4 Ultra-performance liquid chromatography
  • 1.4.5 Nuclear magnetic resonance
  • 1.4.6 Mass spectrometry
  • 1.4.7 Surface-based mass analysis
  • 1.4.8 Bioinformatics
• 1.5 Market by Application
  • 1.5.1 Global Metabolomics Biomarker Market Share by Application: 2020 VS 2026
  • 1.5.2 Toxicological studies
  • 1.5.3 Drug testing
  • 1.5.4 Cancer
  • 1.5.5 Cardiovascular disorders
  • 1.5.6 Neurological disorders
  • 1.5.7 Inborn errors of metabolism
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Metabolomics Biomarker Market Perspective (2015-2026)
• 2.2 Global Metabolomics Biomarker Growth Trends by Regions
  • 2.2.1 Metabolomics Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Metabolomics Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Metabolomics Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Metabolomics Biomarker Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Metabolomics Biomarker Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Metabolomics Biomarker Players by Market Size
  • 3.1.1 Global Top Metabolomics Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Metabolomics Biomarker Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Metabolomics Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Metabolomics Biomarker Market Concentration Ratio
  • 3.2.1 Global Metabolomics Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Metabolomics Biomarker Revenue in 2019
• 3.3 Metabolomics Biomarker Key Players Head office and Area Served
• 3.4 Key Players Metabolomics Biomarker Product Solution and Service
• 3.5 Date of Enter into Metabolomics Biomarker Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Metabolomics Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Metabolomics Biomarker Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Metabolomics Biomarker Market Size by Application (2015-2020)
• 5.2 Global Metabolomics Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Metabolomics Biomarker Market Size (2015-2020)
• 6.2 Metabolomics Biomarker Key Players in North America (2019-2020)
• 6.3 North America Metabolomics Biomarker Market Size by Type (2015-2020)
• 6.4 North America Metabolomics Biomarker Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Metabolomics Biomarker Market Size (2015-2020)
• 7.2 Metabolomics Biomarker Key Players in Europe (2019-2020)
• 7.3 Europe Metabolomics Biomarker Market Size by Type (2015-2020)
• 7.4 Europe Metabolomics Biomarker Market Size by Application (2015-2020)

8 China

• 8.1 China Metabolomics Biomarker Market Size (2015-2020)
• 8.2 Metabolomics Biomarker Key Players in China (2019-2020)
• 8.3 China Metabolomics Biomarker Market Size by Type (2015-2020)
• 8.4 China Metabolomics Biomarker Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Metabolomics Biomarker Market Size (2015-2020)
• 9.2 Metabolomics Biomarker Key Players in Japan (2019-2020)
• 9.3 Japan Metabolomics Biomarker Market Size by Type (2015-2020)
• 9.4 Japan Metabolomics Biomarker Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Metabolomics Biomarker Market Size (2015-2020)
• 10.2 Metabolomics Biomarker Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Metabolomics Biomarker Market Size by Type (2015-2020)
• 10.4 Southeast Asia Metabolomics Biomarker Market Size by Application (2015-2020)

11 India

• 11.1 India Metabolomics Biomarker Market Size (2015-2020)
• 11.2 Metabolomics Biomarker Key Players in India (2019-2020)
• 11.3 India Metabolomics Biomarker Market Size by Type (2015-2020)
• 11.4 India Metabolomics Biomarker Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Metabolomics Biomarker Market Size (2015-2020)
• 12.2 Metabolomics Biomarker Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Metabolomics Biomarker Market Size by Type (2015-2020)
• 12.4 Central & South America Metabolomics Biomarker Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Biocrates Life Sciences
  • 13.1.1 Biocrates Life Sciences Company Details
  • 13.1.2 Biocrates Life Sciences Business Overview
  • 13.1.3 Biocrates Life Sciences Metabolomics Biomarker Introduction
  • 13.1.4 Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2015-2020))
  • 13.1.5 Biocrates Life Sciences Recent Development
• 13.2 Biomark Diagnostics
  • 13.2.1 Biomark Diagnostics Company Details
  • 13.2.2 Biomark Diagnostics Business Overview
  • 13.2.3 Biomark Diagnostics Metabolomics Biomarker Introduction
  • 13.2.4 Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.2.5 Biomark Diagnostics Recent Development
• 13.3 Chenomx
  • 13.3.1 Chenomx Company Details
  • 13.3.2 Chenomx Business Overview
  • 13.3.3 Chenomx Metabolomics Biomarker Introduction
  • 13.3.4 Chenomx Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.3.5 Chenomx Recent Development
• 13.4 Creative Proteomics
  • 13.4.1 Creative Proteomics Company Details
  • 13.4.2 Creative Proteomics Business Overview
  • 13.4.3 Creative Proteomics Metabolomics Biomarker Introduction
  • 13.4.4 Creative Proteomics Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.4.5 Creative Proteomics Recent Development
• 13.5 Evotec
  • 13.5.1 Evotec Company Details
  • 13.5.2 Evotec Business Overview
  • 13.5.3 Evotec Metabolomics Biomarker Introduction
  • 13.5.4 Evotec Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.5.5 Evotec Recent Development
• 13.6 Human Metabolome Technologies
  • 13.6.1 Human Metabolome Technologies Company Details
  • 13.6.2 Human Metabolome Technologies Business Overview
  • 13.6.3 Human Metabolome Technologies Metabolomics Biomarker Introduction
  • 13.6.4 Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.6.5 Human Metabolome Technologies Recent Development
• 13.7 Merck
  • 13.7.1 Merck Company Details
  • 13.7.2 Merck Business Overview
  • 13.7.3 Merck Metabolomics Biomarker Introduction
  • 13.7.4 Merck Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.7.5 Merck Recent Development
• 13.8 Metabolomic Diagnostics
  • 13.8.1 Metabolomic Diagnostics Company Details
  • 13.8.2 Metabolomic Diagnostics Business Overview
  • 13.8.3 Metabolomic Diagnostics Metabolomics Biomarker Introduction
  • 13.8.4 Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.8.5 Metabolomic Diagnostics Recent Development
• 13.9 Metabolon
  • 13.9.1 Metabolon Company Details
  • 13.9.2 Metabolon Business Overview
  • 13.9.3 Metabolon Metabolomics Biomarker Introduction
  • 13.9.4 Metabolon Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.9.5 Metabolon Recent Development
• 13.10 Ovid Therapeutics
  • 13.10.1 Ovid Therapeutics Company Details
  • 13.10.2 Ovid Therapeutics Business Overview
  • 13.10.3 Ovid Therapeutics Metabolomics Biomarker Introduction
  • 13.10.4 Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2015-2020)
  • 13.10.5 Ovid Therapeutics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Metabolomics Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metabolomics Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Biocrates Life Sciences
Biomark Diagnostics
Chenomx
Creative Proteomics
Evotec
Human Metabolome Technologies
Merck
Metabolomic Diagnostics
Metabolon
Ovid Therapeutics

Market segment by Type, the product can be split into
Gas chromatography
High-performance liquid chromatography
Ultra-performance liquid chromatography
Nuclear magnetic resonance
Mass spectrometry
Surface-based mass analysis
Bioinformatics
Market segment by Application, split into
Toxicological studies
Drug testing
Cancer
Cardiovascular disorders
Neurological disorders
Inborn errors of metabolism

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America